Prime Medicine, Inc. Employee Count
The employee counts Prime Medicine, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 146; Filing 2026-03-03; Lease expense per employee $232,842.47.
- 2024-12-31: Employees (as filed) 214; Filing 2025-02-28; Lease expense per employee $113,247.66.
- 2023-12-31: Employees (as filed) 234; Filing 2024-03-01; Lease expense per employee $78,876.07.
- 2022-12-31: Employees (as filed) 175; Filing 2023-03-09; Lease expense per employee $75,525.71.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 146 full-time | 2026-03-03 | $232,842.47 total lease cost |
| 2024-12-31 | 214 full-time | 2025-02-28 | $113,247.66 total lease cost |
| 2023-12-31 | 234 full-time | 2024-03-01 | $78,876.07 total lease cost |
| 2022-12-31 | 175 full-time | 2023-03-09 | $75,525.71 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B |